MedPath

Glucovance

Brand Name: Glucovance

Generic Name: Metformin (as hydrochloride) + Glibenclamide

Active
Registration Number

DR-XY49137

Dosage Form

Film-Coated Tablet

Issuance Date

July 31, 2024

Expiry Date

August 1, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength500 mg/2.50 mg
PackagingClear PVC/Alu Blister Pack x 15's (Box of 30's) of 30's)

Classification

C
Classification
Prescription (Rx) Drug
P
Pharmacologic
Blood Glucose Lowering Drug (Biguanide/Sulfonylurea)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

Metformin (as hydrochloride)Active
Monograph: metformin (as hydrochloride)
GlibenclamideActive
Monograph: Glyburide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform